Lucosky Brookman LLP represented Modular Medical, Inc. (Nasdaq: MODD) in connection with its private placement transaction, expected to generate gross proceeds of approximately $12 million before fees and expenses.
Modular Medical, a San Diego-based insulin delivery technology company and developer of the first FDA-cleared patch pump designed specifically for the needs of “almost-pumpers,” executed definitive subscription agreements with a group of institutional and accredited investors for the private placement of units priced at $1.92 per unit, at-the-market under Nasdaq rules.
